Successful treatment of severe cytokine release syndrome after CAR-T therapy by ruxolitinib without compromising CAR-T efficacy

Authors:Gu, Chengyuan; Wu, Qian; Zhang, Jingren; Kang, Liqing; Yu, Lei; Qiu, Huiying; Wu, Depei; Chen, Suning; Yang, Xiaofei*
Source:LEUKEMIA & LYMPHOMA, 2023, 64(2): 495-498.
DOI:10.1080/10428194.2022.2148209
  • Institution
    1; 苏州大学

Full-Text